Cantor Fitzgerald Maintains Overweight on Globus Medical, Raises Price Target to $64

Cantor Fitzgerald maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $55 to $64.

Benzinga · 11/07/2019 11:56

Cantor Fitzgerald maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $55 to $64.